Sanofi SA at Goldman Sachs Global Healthcare Conference Transcript
Good morning, and thank you all for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. Bill, thank you very much for joining us.
Pleasure to be here.
The business has been -- [albeit just China was down], kind of the business has been in a great shape this year, and if you want to make a few introductory comments on how do you see the business kind of for the next kind of year or so and then we can go straight to Q&A from there?
Yes. That's great. So yes, look, we're off to a strong first quarter and really delivering on this goal of return to growth for Sanofi. At constant exchange rates from a sales and EPS perspective, we grew 4.2% and 9.4%, respectively. So one of the things I was excited about was double
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
